Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 4 Study of Role of 'Pentoxifylline and or IgM Enriched Intravenous Immunoglobulin in the Treatment of Neonatal Sepsis'

NCT01006499 is registered in ClinicalTrials.gov with Zekai Tahir Burak Women's Health Research and Education Hospital as lead sponsor.

NCT NCT01006499
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01006499 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 4 Study of Role of 'Pentoxifylline and or IgM Enriched Intravenous Immunoglobulin in the Treatment of Neonatal Sepsis'
Lead sponsor
Zekai Tahir Burak Women's Health Research and Education Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
August 31, 2009
Completion date
December 31, 2010
Enrollment
204 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis of the newborn